Medical Inventi S.A. has received funding from the European Union

Medical Inventi S.A. has received funding from the European Union for the implementation of a project entitled: FlexiOss^®Dent non-inferiority clinical trial. Comparative evaluation of the efficacy of a novel synthetic bone matrix with current standards used in the treatment and regeneration of the post-extraction alveolus.

The project will be carried out under the National Recovery and Resilience Plan, as part of Investment D3.1.1 “Comprehensive development of research in medical sciences and health sciences.”

The main objective of the project is to conduct a clinical trial that will demonstrate the potential of using FlexiOss^®Dent material for socket preservation to prevent bone loss, maintain bone volume and structure, and support proper regeneration of bone tissue. The study will compare the efficacy of FlexiOss^®Dent to another biomaterial currently most commonly used.

The research results will be used, among other things, to complete an application for certification of the product in accordance with the MDR regulation and to introduce innovative methods for alveolar ridge preservation in implantology procedures on the Polish and European markets.

Project value: PLN 3,378,744.86
European Union contribution: PLN 2,027,246.92